NCT03264664View on ClinicalTrials.gov

Study of E7386 in Participants With Selected Advanced Neoplasms

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 27, 2017

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Advanced Neoplasms
Interventions
DRUG

E7386

Oral immediate release tablets.

Trial Locations (10)

32224

Mayo Clinic Comprehensive Cancer, Jacksonville

55905

Mayo Clinic Comprehensive Caner, Rochester

85054

Mayo Clinic Comprehensive Caner, Phoenix

90033

USC Norris Comprehensive Cancer Center, Los Angeles

91105

California Liver Research Institute, Pasadena

G12 0YN

The Beatson West of Scotland Cancer Centre, Glasgow

M20 4BX

The Christie NHS Foundation Trust, Manchester

SM2 5PT

Royal Marsden Hospital NHS Foundation Trust, Sutton

NW3 2QG

Royal Free London NHS Foundation Trust, Royal Free Hospital, London

W2 1NY

Imperial College Healthcare NHS Trust, London

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY